SGC707 is primarily utilized in biochemical research as a potent and selective inhibitor of the protein arginine methyltransferase 5 (PRMT5). It is employed in studies aimed at understanding the role of PRMT5 in various cellular processes, including gene expression, RNA splicing, and cell cycle regulation. Researchers use SGC707 to investigate its potential therapeutic applications in cancers where PRMT5 is overexpressed or dysregulated. Additionally, it serves as a valuable tool in the development of targeted therapies for diseases linked to abnormal PRMT5 activity. Its specificity makes it a critical compound for exploring epigenetic mechanisms and identifying novel drug candidates.